Femtobiomed Inc. Logo

Femtobiomed Inc.

Develops a non-viral intracellular delivery platform for cell and gene therapy.

327610 | KO

Overview

Corporate Details

ISIN(s):
KR7327610002
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 700D동 510호(야탑동, 분당테크노파크), 성남시

Description

Femtobiomed Inc. is a cell engineering company that develops technologies for the cell and gene therapy industry. The company's core offering is the CellShot® platform, a proprietary, non-viral intracellular delivery system. This platform utilizes a patented technology known as 'Partitioned Flow Transfection,' which functions as a three-dimensional nanoinjection system for the direct, cargo-free delivery of biomolecules into individual cells. The technology is designed to support the discovery and development of advanced therapeutics, including anti-cancer treatments, for the healthcare and research sectors. Femtobiomed aims to pioneer non-viral cell engineering to accelerate the creation of novel cell therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-06-25 00:00
주요사항보고서(무상증자결정)
Korean 10.3 KB
2021-06-25 00:00
주권매매거래정지(무상증자)
Korean 4.7 KB
2021-06-25 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.2 KB
2021-06-15 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2021-06-15 00:00
주식등의대량보유상황보고서(일반)
Korean 116.2 KB
2021-06-09 00:00
주식매수선택권부여에관한신고
Korean 18.4 KB
2021-05-28 00:00
기업설명회(IR)개최결과
Korean 6.6 KB
2021-05-21 00:00
기업설명회(IR)개최
Korean 6.9 KB
2021-04-27 00:00
특허권취득(자율공시)(세포에 물질을 주입하는 장치 및 제조방법)
Korean 4.9 KB
2021-03-26 00:00
정기주주총회결과
Korean 20.3 KB
2021-03-18 00:00
감사보고서제출
Korean 10.5 KB
2021-03-18 00:00
[첨부추가]사업보고서 (2020.12)
Korean 1001.4 KB
2021-03-11 00:00
주주총회소집공고
Korean 57.9 KB
2021-03-04 00:00
주식등의대량보유상황보고서(약식)
Korean 57.6 KB
2021-03-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 23.5 KB

Automate Your Workflow. Get a real-time feed of all Femtobiomed Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Femtobiomed Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Femtobiomed Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CRONEX.CO.,LTD Logo
A CRO supplying biological species and bio-tissue materials for medical research.
South Korea
215570
C&R Research Inc. Logo
A full-service CRO providing clinical research for pharma and medical device companies.
South Korea
359090
Cte Group Spolka Akcyjna Logo
Diversified firm in HR services, corporate events, and composite materials.
Poland
LPS
curacle co., ltd. Logo
A clinical-stage biopharma developing drugs for intractable vascular diseases.
South Korea
365270
CytoMed Therapeutics Ltd Logo
Clinical-stage developer of off-the-shelf allogeneic cell immunotherapies for cancer.
United States of America
GDTC
Cyxone AB Logo
A clinical-stage biotech developing therapies for autoimmune and autoinflammatory diseases.
Sweden
CYXO
DARWIN AG Logo
Biotechnology firm creating personalized products from individual biological data.
Germany
7V0
DEINOVE Logo
Develops compounds from rare bacteria for cosmetics and new antibiotics.
France
ALDEI
Delta Drone Logo
Develops drone-based systems for the logistics, security, and military sectors.
France
ALDR
Delta-Fly Pharma, Inc. Logo
Biopharmaceutical firm developing novel anticancer drugs from existing components.
Japan
4598

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.